Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
NCT07049575
This study is recruiting at 16 US sites in 11 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hidradenitis Suppurativa
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 12 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Incyte Corporation
- Last updated on ClinicalTrials.gov
- October 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Saguaro Dermatology · Phoenix, AZ
California · 3
- Amicis Research Center Valencia · Northridge, CA
- Children'S Hospital of Orange County · Orange, CA
- Clinical Trials Research Institute · Thousand Oaks, CA
Florida · 3
- International Clinical Research Tennessee Llc · Sanford, FL
- Lenus Research Medical Group, Llc · Sweetwater, FL
- Trueblue Clinical Research · Tampa, FL
Georgia · 1
- Lane Dermatology and Dermatologic Surgery · Columbus, GA
Indiana · 1
- Options Research Group, Llc · West Lafayette, IN
Kentucky · 1
- Equity Medical, Llc · Bowling Green, KY
Louisiana · 1
- Delricht Research · Baton Rouge, LA
Missouri · 1
- Red River Research Partners · Bolivar, MO
New York · 2
- Dr Bobby Buka, Md Greenwich Village · New York, NY
- Equity Medical, Llc · New York, NY
North Dakota · 1
- Red River Research Partners · Fargo, ND
Oklahoma · 1
- Unity Clinical Research · Oklahoma City, OK
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.